August 30, 2021 - The Bulls Wire

Read Time:4 Minute, 36 Second

The market started off the week on a solid note and continued its uptrend for the second consecutive session of the September series, ending at...

Read Time:1 Minute, 36 Second

Ports

Jawaharlal Nehru port trust to introduce voluntary retirement plan from Sept 1,2021.

Team Bullswire

August 30, 2021August 30, 2021

Jawaharlal Nehru Port Trust has secured backing from the government to introduce a special voluntary retirement scheme (SVRS) for employees from September 1, after it...

Read Time:1 Minute, 27 Second

pharma pharma companies pharma sector pharma sensex

Dr. Reddys Lab and Zydus Pharma to recall drugs from U.S.

Team Bullswire

August 30, 2021August 30, 2021

Leading drug makers Dr Reddy's Laboratories and Zydus Pharma are recalling bottles of a product each, in the US market, for different reasons, according to the latest...

Breaking News

Soli Merwan Cama: The Visionary Producer Redefining Bollywood’s Global Footprint

Dr. Shibani Staney Honored as Midday Powerful Women Icon 2025

Nimaaya Women’s Centre for Health organises ‘Nimaaya GR8 Run’ on Women’s Day

Abhijeeth Bhattacharjee and Sangitanjaly Foundation Celebrates International Women’s Day in Hyderabad

Numax: Team Sunil Goel Celebrates India’s Champions Trophy Win with Associates from Gwalior and Muzaffarnagar

Tanaji Bhimaji Gargote Crowned IRG Champion at South Asia’s First Mind Sports Championship’s West Zone Finals

Super Iron Foundry Ltd plans to raise up to Rs. 68.05 crore from Public Issue; IPO opens on March 11

Parvati Jangid Suthar: The ‘Sister of Soldiers’ Named Among World’s Most Extraordinary Women by Harvard100

Robin Uthappa’s Amazing Cricket Predictions Inspires Champions to Write New Script of Resurgence

Satyam Fashion Institute Hosts Satyam’s Triptych 2025: A Grand Showcase of Design Creativity

Trade Setup Tuesday after rock solid start on Monday.

Jawaharlal Nehru port trust to introduce voluntary retirement plan from Sept 1,2021.

Dr. Reddys Lab and Zydus Pharma to recall drugs from U.S.